for Journals by Title or ISSN
for Articles by Keywords
help
Followed Journals
Journal you Follow: 0
 
Sign Up to follow journals, search in your chosen journals and, optionally, receive Email Alerts when new issues of your Followed Journals are published.
Already have an account? Sign In to see the journals you follow.
Journal Cover The Rose Sheet
  [1 followers]  Follow
    
   Full-text available via subscription Subscription journal
   ISSN (Print) 1530-1222
   Published by Informa plc Homepage  [16 journals]
  • New REACH Rules Will Reduce Animal Use For Assessing Sensitization, Other
           Endpoints
    • Abstract: Alternative testing methods addressing key events in the OECD's adverse outcome pathway for skin sensitization may be sufficient to fulfill REACH data needs under a new rule slated for implementation later this year. Another pending change is expected to reduce firms' dependence on animal tests to evaluate skin and eye irritation and acute toxicity as the final REACH deadline for phase-in substances draws closer.
      PubDate: Tue, 24 May 2016 15:05:02 -040
       
  • Consumer Reports To Alert FDA: Half Of Sunscreens Perform Short Of SPF
           Claims
    • Abstract: The Personal Care Products Council continues to question Consumer Reports' methods for testing products' SPF levels, which may not be consistent with FDA standards. Over the four years that CR has been putting sunscreens to the test, 48% have failed to meet claimed SPFs, with mineral sunscreens testing as particularly unreliable, the magazine says.
      PubDate: Tue, 24 May 2016 15:00:00 -040
       
  • J&J Baby Care Focuses On 'Premiumization,' E-Commerce For Growth
    • Abstract: Executives during an investor day presentation were mum on J&J's legal woes concerning talc in Johnson's baby powder, but acknowledged that the firm's baby-care business faces challenges. Execs heralded an upcoming transformation of the firm's iconic brand, among other planned moves to grow in a market segment it dominates.
      PubDate: Mon, 23 May 2016 16:55:01 -040
       
  • FDA Warns Reviva Labs For Collagen-Building, Anti-Inflammatory Claims
    • Abstract: FDA cites Reviva for unapproved drug claims on eight of its products marketed as cosmetics. Included among targeted claims are familiar statements about collagen production, inflammation reduction and other benefits the agency views as structure/function effects.
      PubDate: Mon, 23 May 2016 00:02:08 -040
       
  • Weekly Trademark Review May 17, 2016
    • Abstract: Class 3 (Cosmetics and Cleaning Preps) compiled by “The Rose Sheet” from Official Gazette of the U.S. Patent and Trademark Office Product Name Trademark No./ Serial No. Company Filed Date Published Class Nos.
      PubDate: Mon, 23 May 2016 00:00:42 -040
       
  • J&J Banking On Beauty Devices, 'Rapid' Anti-Aging For Consumer
           Growth
    • Abstract: During an investor day conference held May 18, Johnson & Johnson execs discussed the firm's consumer business at length, offering a preview of dynamic new launches planned for the year.
      PubDate: Fri, 20 May 2016 15:40:01 -040
       
  • FDA Highlights Potential Benefits Of OTC Monograph User Fees
    • Abstract: FDA schedules a public meeting June 10 and opens a docket for stakeholder input on the potential development of a user-fee program for OTC monograph drugs. CDER points out the OTC monograph is "one of the largest and most complex regulatory programs ever undertaken at FDA."
      PubDate: Fri, 20 May 2016 03:20:00 -040
       
  • What Comes First In FDA Land, Excessive Claims Finding Or Facility
           Inspection'
    • Abstract: Recent warning letters to Reviva Labs and Ageless Derma manufacturer Crescent Health Center cite claims violations brought to FDA's attention through inspections of the companies' manufacturing facilities. It's possible, however, that conspicuous website claims that overstep cosmetic boundaries are prompting inspections – further reason for companies to keep their claims in check.
      PubDate: Thu, 19 May 2016 22:15:03 -040
       
  • Lauder Tailoring Strategy To Meet Millennials, Makeup Demand
    • Abstract: Lauder is deemphasizing anti-aging in favor of instant-benefit skin care and positioning skin care as a base for optimal makeup results, among other tactics to engage Millennials and drive sales. Company executives discussed Lauder's evolving approach across product categories, along with a new cost-savings initiative dubbed Leading Beauty Forward, during its third-quarter earnings calls May 3.
      PubDate: Thu, 19 May 2016 16:50:02 -040
       
  • Eclipse Aesthetics Runs Afoul Of FDA Again For Uncleared Beauty Device
    • Abstract: Following an October 2015 warning letter for marketing an FDA-cleared medical device for unapproved cosmetic indications, Eclipse is targeted for marketing its MicroPen Elite micro-needling device as a safe alternative to other skin-resurfacing techniques without required premarket authorization.
      PubDate: Tue, 17 May 2016 16:00:00 -040
       
  • Arden Scoops Up Christina Aguilera License From
           P&G
    • Abstract: Previously intended for Coty under its merger deal with P&G, the Christina Aguilera fragrance license increases Elizabeth Arden's exposure to the vagaries of the celebrity-scent market, but could offer a boost to its European business. The firm reported growing sales in the third quarter, excluding currency effects, as its turnaround progresses.
      PubDate: Tue, 17 May 2016 10:55:00 -040
       
  • Revlon Brand 'Bigger Than Its Current State' –
           New CEO Garcia
    • Abstract: In his first quarterly call with analysts after coming on board with Revlon Inc. less than a month ago, new President and CEO Fabian Garcia offered his assessment of the company and its prospects for the future.
      PubDate: Mon, 16 May 2016 00:01:39 -040
       
  • Weekly Trademark Review May 10, 2016
    • Abstract: Class 3 (Cosmetics and Cleaning Preps) compiled by “The Rose Sheet” from Official Gazette of the U.S. Patent and Trademark Office Product Name Trademark No./ Serial No. Company Filed Date Published Class Nos.
      PubDate: Mon, 16 May 2016 00:01:07 -040
       
  • In Brief: Essential Oils Sector Squared For REACH; New Beauty Association;
           More
    • Abstract: A joint effort between the essential oils sector, IFRA and European regulators has positioned the industry for May 2018 registration under REACH, which has posed unique challenges for natural substances. Meanwhile, a San Francisco-based beauty association launches and Brand Finance unveils its list of the world's most valuable cosmetic brands.
      PubDate: Fri, 13 May 2016 15:05:02 -040
       
  • Study: Popular Chemical Hazard Assessment Tools Yield Widely Different
           Results
    • Abstract: Retailers and personal-care manufacturers should take context into account when using hazard assessment tools and communicating findings to the consumers they serve – let alone replacing ingredients with "greener" alternatives – as different approaches can generate widely varying outcomes, a new study suggests.
      PubDate: Fri, 13 May 2016 11:10:01 -040
       
  • Aquafresh Ads For 24HR Sugar Acid Protection
           Overstate Fluoride Benefit
    • Abstract: The Advertising Standards Authority agrees with GlaxoSmithKline's decision to withdraw ads in the UK for Aquafresh 24HR Sugar Acid Protection toothpastes. According to ASA's ruling, the ads in question imply without proper substantiation that users receive continuous protection between brushing even when frequently consuming sugary foods.
      PubDate: Thu, 12 May 2016 19:00:00 -040
       
  • Biossance Doubles Down On 'Free Of' Marketing With Ingredient Blacklist
    • Abstract: Biossance, the personal-care division of integrated renewable products company Amyris, has unveiled a blacklist of more than 2,000 cosmetic ingredients it "refuses to use" due to safety and environmental concerns. The company discusses its rationale for the move and the controls it has in place in a litigious environment where "free of" claims are under increasing attack.
      PubDate: Thu, 12 May 2016 17:20:01 -040
       
  • Prop 65 Problems Are Deeper Than Rulemaking Can Solve – ACC
    • Abstract: The American Chemistry Council is convinced that the answer to Prop 65's failings is not likely to be found in further regulatory proposals from California's Office of Environmental Health Hazard Assessment. The legislative foundation itself is the problem, the trade group asserts in its latest comments to the agency.
      PubDate: Wed, 11 May 2016 14:20:01 -040
       
  • Inside The Coty/P&G Beauty Mega Deal
    • Abstract: Coty faced off against 44 other interested parties last year to eventually win P&G's beauty business with its $12.5bn merger bid, ushering it to the top tier of the global beauty industry. An April 21 SEC filing offers inside details on Coty and P&G's businesses and how the deal came together.
      PubDate: Wed, 11 May 2016 10:45:02 -040
       
  • FDA Warning Cites Ageless Derma's Anti-Wrinkle,
           Brightening Claims
    • Abstract: In a warning letter published on FDA's website May 2, the agency identifies two Ageless Derma products as unapproved new drugs due to label and website claims touting body structure/function effects. The laundry list of offending claims offers a resource for companies to use in their own claims-compliance efforts.
      PubDate: Mon, 09 May 2016 00:00:59 -040
       
  • Weekly Trademark Review May 4, 2016
    • Abstract: Class 3 (Cosmetics and Cleaning Preps) compiled by “The Rose Sheet” from Official Gazette of the U.S. Patent and Trademark Office Product Name Trademark No./ Serial No. Company Filed Date Published Class Nos.
      PubDate: Mon, 09 May 2016 00:00:24 -040
       
  • Coty Projects Higher Costs For P&G Deal, Orphan Brand Challenges
    • Abstract: Costs associated with integrating 41 P&G beauty brands are estimated to reach $1.2bn over the next four years, more than doubling Coty's projections when the mega-deal was announced last year, and investments will be needed to galvanize the currently under-supported orphan assets. However, Coty is projecting $780m in synergies and room for further growth as a $9bn beauty force to be reckoned with.
      PubDate: Thu, 05 May 2016 16:25:00 -040
       
  • Call For End To 'War On Face Wash' Comes Late For US
    • Abstract: Study findings show that plastic microbeads' presence in water is minimal where fish actually feed, and fish aren't attracted to them regardless, a University of Michigan professor and research director suggests in a recent op-ed published by The Detroit News. The ingredients' use in cosmetics is already banned in the US, but European member states are exploring similar regulations and pushing for EU-wide action.
      PubDate: Thu, 05 May 2016 10:05:01 -040
       
  • L'Oreal Kicks Off FY 2016 With Consumer Biz Acceleration, NA Share Gains
    • Abstract: Firm reports 4.2% like-for-like growth for the fiscal 2016 first quarter, driven by improvements in North America and the best performance from its Consumer Products division in almost three years. Analysts see the results as an affirmation that L'Oreal's competitive edge remains sharp.
      PubDate: Wed, 04 May 2016 19:00:01 -040
       
  • Jury Still Out On Feminine-Hygiene Talc Safety, Except In The Courts
    • Abstract: Health and scientific authorities have taken various positions on the possible link between perineal talcum-powder use and ovarian cancer, including that the substance is safe as used, is "possibly carcinogenic" and that data is insufficient to allow for a conclusive assessment. Juries in J&J talc trials have been more convinced of the talc-cancer correlation and the firm's negligence in not warning consumers about risks.
      PubDate: Wed, 04 May 2016 12:15:01 -040
       
 
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
Fax: +00 44 (0)131 4513327
 
About JournalTOCs
API
Help
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-2015